WO2001012659A3 - Human dna sequences - Google Patents

Human dna sequences Download PDF

Info

Publication number
WO2001012659A3
WO2001012659A3 PCT/IB2000/001496 IB0001496W WO0112659A3 WO 2001012659 A3 WO2001012659 A3 WO 2001012659A3 IB 0001496 W IB0001496 W IB 0001496W WO 0112659 A3 WO0112659 A3 WO 0112659A3
Authority
WO
WIPO (PCT)
Prior art keywords
clones
sequence
dna sequences
human dna
disclosed sequence
Prior art date
Application number
PCT/IB2000/001496
Other languages
French (fr)
Other versions
WO2001012659A2 (en
Inventor
Stefan Wiemann
Annemarie Poustka
Ruth Wellenreuther
Original Assignee
Fraunhofer Ges Forschung
Stefan Wiemann
Annemarie Poustka
Ruth Wellenreuther
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fraunhofer Ges Forschung, Stefan Wiemann, Annemarie Poustka, Ruth Wellenreuther filed Critical Fraunhofer Ges Forschung
Priority to EP00966368A priority Critical patent/EP1248798A2/en
Priority to AU76803/00A priority patent/AU7680300A/en
Publication of WO2001012659A2 publication Critical patent/WO2001012659A2/en
Publication of WO2001012659A3 publication Critical patent/WO2001012659A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Novel human cDNA sequence of a clones, the encoded protein sequence of a clones, antibodies and variants thereof, are provided. The disclosed sequence of a clones find application in a number of ways, including use in profiling assays. In this regard, various assemblages of nucleic acids or proteins are provided that are useful in providing large arrays of human material for implementing large-scale screening strategies. The disclosed sequence of a clones may also be used in formulating medicaments, treating various disorders and in certain diagnostic applications.
PCT/IB2000/001496 1999-08-18 2000-08-18 Human dna sequences WO2001012659A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP00966368A EP1248798A2 (en) 1999-08-18 2000-08-18 Human dna sequences
AU76803/00A AU7680300A (en) 1999-08-18 2000-08-18 Human dna sequences

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US14949999P 1999-08-18 1999-08-18
US15650399P 1999-08-18 1999-08-18
US60/149,499 1999-08-18
US60/156,503 1999-09-28

Publications (2)

Publication Number Publication Date
WO2001012659A2 WO2001012659A2 (en) 2001-02-22
WO2001012659A3 true WO2001012659A3 (en) 2002-06-20

Family

ID=26846790

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2000/001496 WO2001012659A2 (en) 1999-08-18 2000-08-18 Human dna sequences

Country Status (3)

Country Link
EP (1) EP1248798A2 (en)
AU (1) AU7680300A (en)
WO (1) WO2001012659A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9475873B2 (en) 2009-05-05 2016-10-25 Novimmune Sa Nucleic acids encoding anti-IL-17F antibodies and methods of use thereof

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7771719B1 (en) 2000-01-11 2010-08-10 Genentech, Inc. Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
US20040058355A1 (en) 1998-09-30 2004-03-25 Millennium Pharmaceuticals, Inc. Novel 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, H1983, M1983, 38555 or 593 molecules and uses therefor
US7001752B1 (en) 1999-05-28 2006-02-21 Immunex Corporation Murine and human kinases
CA2374612A1 (en) 1999-05-28 2000-12-07 Immunex Corporation Novel murine and human kinases
KR100543857B1 (en) * 1999-09-01 2006-01-23 제넨테크, 인크. Promotion or Inhibition of Angiogenesis and Cardiovascularization
JP2003528581A (en) * 1999-09-24 2003-09-30 レキシコン・ジェネティクス・インコーポレーテッド Novel human protein like protease inhibitor and polynucleotide encoding the same
CA2391805A1 (en) * 1999-10-06 2001-04-12 The Regents Of The University Of California Differentially expressed genes associated with her-2/neu overexpression
US6770477B1 (en) 1999-10-06 2004-08-03 The Regents Of The University Of California Differentially expressed genes associated with HER-2/neu overexpression
EP1897946B1 (en) * 1999-12-23 2012-07-11 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
WO2001059114A2 (en) * 2000-02-09 2001-08-16 The Government Of The United States Of America, As Represented By The Secretary Of Health And Human Services Tumor suppressor gene, p47ing3
EP1259620A2 (en) 2000-02-29 2002-11-27 Millennium Pharmaceuticals, Inc. 2504, 15977, and 14760, novel protein kinase family members and uses therefor
CA2403370A1 (en) * 2000-03-16 2001-09-15 Amgen Inc. Il-17 receptor like molecules and uses thereof
CA2407656A1 (en) * 2000-04-27 2001-11-08 Kyowa Hakko Kogyo Co. Ltd. Myocardial cell proliferation-associated genes
US20010049106A1 (en) * 2000-04-27 2001-12-06 Leonard Buckbinder ADAMTS polypeptides, nucleic acids encoding them, and uses thereof
WO2001085942A2 (en) * 2000-05-05 2001-11-15 Incyte Genomics, Inc. Cytoskeleton-associated proteins
WO2001092310A2 (en) * 2000-05-31 2001-12-06 Bayer Aktiengesellschaft Regulation of human transketolase-like enzyme
US20030096969A1 (en) 2000-06-02 2003-05-22 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2001269078A1 (en) * 2000-06-19 2002-01-02 Boehringer Ingelheim International G.M.B.H Cyk-4 polypeptides, dna molecules encoding them and their use in screening methods
EP1254912A1 (en) * 2001-04-30 2002-11-06 Boehringer Ingelheim International GmbH Cyk-4 polypeptides, DNA molecules encoding them and their use in screening methods
US20030105288A1 (en) * 2000-07-25 2003-06-05 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6534309B1 (en) * 2000-08-03 2003-03-18 Cytokinetics, Inc. Motor proteins and methods for their use
AU2001292769A1 (en) * 2000-09-20 2002-04-02 Pe Corporation (Ny) Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
AU2001294741A1 (en) * 2000-09-25 2002-04-02 Millennium Pharmaceuticals, Inc. 3700, a novel human protein kinase and uses therefor
TW499433B (en) 2000-12-27 2002-08-21 Ind Tech Res Inst Novel human Α1-chain collagen
US20030104385A1 (en) * 2001-08-02 2003-06-05 Evans Glen A. Nucleic acids and encoded polypeptides associated with bipolar disorder
AU2002328200B2 (en) * 2001-09-27 2008-01-03 Bionomics Limited DNA sequences for human angiogenesis genes
NZ554534A (en) * 2001-09-27 2008-10-31 Bionomics Ltd DNA sequences for human angiogenesis genes
US7858297B2 (en) 2001-12-18 2010-12-28 Centre National De La Recherche Scientifique Cnrs Chemokine-binding protein and methods of use
DE60234713D1 (en) * 2001-12-18 2010-01-21 Endocube Sas NEW PROTEINS ASSOCIATED WITH CELL-DATE FROM THE THAP FAMILY AND PAR4 RELATED SIGNALING PATHS INVOLVED IN THE CONTROL OF APOPTOSIS
JP2004097199A (en) * 2002-07-15 2004-04-02 Keio Gijuku Method for screening tumor antigen
JPWO2004015110A1 (en) * 2002-08-07 2005-12-02 独立行政法人産業技術総合研究所 Glycosynthetic genes
WO2004018669A1 (en) * 2002-08-21 2004-03-04 Proteinexpress Co., Ltd. Salt-inducible kinases 2 and use thereof
EP1578364A4 (en) * 2002-09-16 2011-06-08 Genentech Inc Compositions and methods for the treatmentof immune related diseases
DK1400589T3 (en) 2002-09-18 2006-11-27 Sirs Lab Gmbh Method for Detecting Prokaryotic DNA
JP2006512923A (en) * 2002-10-18 2006-04-20 エルジー ライフサイエンス リミテッド Cancer-related gene family
US7423018B2 (en) * 2002-12-13 2008-09-09 University Of Massachusetts Kinesin-like proteins and methods of use
WO2005056838A1 (en) * 2003-12-08 2005-06-23 The Clinic For Special Children Association of tspyl polymorphisms with siddt syndrome
ES2384571T3 (en) * 2004-03-05 2012-07-09 Sirs-Lab Gmbh Procedure for enrichment and / or separation of prokaryotic DNA by a protein that specifically binds to DNA containing unmethylated CpG motifs
WO2005089429A2 (en) * 2004-03-17 2005-09-29 University Of Virginia Patent Foundation Sfec, a sperm flagellar energy carrier protein
MX2007002043A (en) 2004-08-16 2007-10-11 Quark Biotech Inc Therapeutic uses of inhibitors of rtp801.
US20110177079A1 (en) * 2004-09-08 2011-07-21 Ludwig Institute For Cancer Research Cancer-testis antigens
US7332591B2 (en) * 2004-12-21 2008-02-19 The University Of Iowa Research Foundation Bardet-Biedl susceptibility gene and uses thereof
UY30097A1 (en) 2006-01-20 2007-08-31 Atugen Ag THERAPEUTIC USES OF RTP801 INHIBITORS
US7825099B2 (en) 2006-01-20 2010-11-02 Quark Pharmaceuticals, Inc. Treatment or prevention of oto-pathologies by inhibition of pro-apoptotic genes
GB2450840B (en) 2006-05-11 2010-12-29 Quark Pharmaceuticals Inc Screening Systems Utilizing RTP801
WO2007141796A2 (en) 2006-06-09 2007-12-13 Quark Pharmaceuticals, Inc. Therapeutic uses of inhibitors of rtp801l
JP2010518880A (en) 2007-02-26 2010-06-03 クアーク・ファーマスーティカルス、インコーポレイテッド Inhibitors of RTP801 and their use in the treatment of diseases
US8614311B2 (en) 2007-12-12 2013-12-24 Quark Pharmaceuticals, Inc. RTP801L siRNA compounds and methods of use thereof
EP2288382B1 (en) 2008-05-05 2018-08-29 NovImmune SA Anti- il-17a/il-17f cross-reactive antibodies and methods of use thereof
EP2411534B1 (en) * 2009-03-24 2016-06-01 INSERM - Institut National de la Santé et de la Recherche Médicale Method for diagnosing or predicting a non syndromic autosomal recessive optic atrophy, or a risk of a non syndromic autosomal recessive optic atrophy.
CN103421742B (en) * 2013-05-31 2015-01-28 华中农业大学 Recombinant monoclonal antibodies H2 resisting fumonisins B1
CN103421743B (en) * 2013-05-31 2015-01-28 华中农业大学 Recombinant monoclonal antibodies H7 resisting fumonisins B1
DE102020210725A1 (en) * 2019-10-31 2021-05-06 Gelita Ag Nutritionally optimized collagen peptide

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998040486A2 (en) * 1997-03-14 1998-09-17 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO2000009552A1 (en) * 1998-08-14 2000-02-24 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998040486A2 (en) * 1997-03-14 1998-09-17 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO2000009552A1 (en) * 1998-08-14 2000-02-24 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
"Atlas(tm) human cDNA expression array I", CLONTECHNIQUES, April 1977 (1977-04-01), US, pages 4 - 7, XP002914393 *
HILLIER L ET AL.: "Human cDNA clone IMAGE: 754167", EMBL SEQUENCE DATABASE, 23 June 1997 (1997-06-23), HEIDELBERG DE, XP002163419 *
HILLIER L ET AL.: "Human cDNA clone IMAGE:263887", EMBL SEQUENCE DATABASE, 5 January 1996 (1996-01-05), HEIDELBERG DE, XP002163421 *
HILLIER L ET AL: "Human cDNA clone IMAGE:754267", EMBL SEQUENCE DATABASE, 23 July 1997 (1997-07-23), HEIDELBERG DE, XP002163418 *
REICHERT J ET AL: "HUMAN AND RODENT EXPRESSION PATTERN OF A FUSION GENE ISOLATED FROM AN MCF7 CDNA LIBRARY", INTERNATIONAL JOURNAL OF ONCOLOGY, vol. 9, no. 1, 1996, pages 29 - 32, XP000906725 *
STRAUSBERG R ET AL.: "Human cDNA sequence IMAGE:2138166", EMBL SEQUENCE DATABASE, 24 March 1999 (1999-03-24), HEIDELBERG DE, XP002163420 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9475873B2 (en) 2009-05-05 2016-10-25 Novimmune Sa Nucleic acids encoding anti-IL-17F antibodies and methods of use thereof

Also Published As

Publication number Publication date
AU7680300A (en) 2001-03-13
EP1248798A2 (en) 2002-10-16
WO2001012659A2 (en) 2001-02-22

Similar Documents

Publication Publication Date Title
WO2001012659A3 (en) Human dna sequences
CA2294516A1 (en) Ikk-.beta. proteins, nucleic acids and methods
ATE418563T1 (en) NIK PROTEINS, NUCLEIC ACID AND METHODS
WO2000054046A3 (en) Universal protein array system
WO2002008285A3 (en) Il-17 molecules and uses thereof
WO1996001614A3 (en) Rna component of telomerase
EP2130920A3 (en) Beta-like glycoprotein hormone polypeptide and heterodimer
CA2294566A1 (en) Ikk-.alpha. proteins, nucleic acids and methods
WO2002012338A3 (en) Screening method
WO1998006841A3 (en) Two human nsp-like proteins
CA2336261A1 (en) Cyclin e2 genes and proteins
CA2495529A1 (en) Noonan syndrome gene
DE69736801D1 (en) CLEANED PROTEINS, RECOMBINANT DNA SEQUENCES AND PROCESSES FOR THE PRODUCTION OF CASE-FREE DRINKS
BR0000698A (en) Beta 15, 15'-dioxigenases, beta-carotene
WO2001064876A3 (en) Human schizophrenia gene
WO2001032693A3 (en) Trp-protein-related mtr1 protein and dna sequence coding therefor
EP0780472A3 (en) Stress proteins
WO2000043510A3 (en) Ras activator nucleic acid molecules - guanine nucleotide releasing factor grf4, polypeptides and methods of use
WO2001087932A3 (en) Seven transmembrane proteins and polynucleotides encoding the same
WO2001040461A3 (en) Cdna sequence of two interactors fancip4 and fancip5 of the fanconi anaemia proteins of the complementation groups a and c
WO1998018942A3 (en) Novel human rab proteins
DE69631624D1 (en) ANTIBODIES AGAINST HUMAN RESTRICTIN
WO1998036068A3 (en) Human p24 vesicle proteins
AU2001253804A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof
WO2001094417A3 (en) Novel human seven transmembrane proteins and polynucleotides encoding the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2000966368

Country of ref document: EP

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2000966368

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2000966368

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP